2022-23 Federal Budget Submission

Friday 4th February 2022


The Pharmaceutical Society of Australia (PSA) has called on the Federal Government to implement four key measures in its 2022-23 Budget Submission, enabling pharmacists to further improve health outcomes for Australians, particularly in residential aged care facilities and in regional Australia; and addressing unfair disparities that exist in pharmacist remuneration.


PSA National President, A/Prof Chris Freeman, said that embedded pharmacists in Australia’s aged care workforce is well overdue.


“Ahead of next month’s Federal Budget, PSA has outlined to the Federal Government four key asks aimed at improving access to medicines and health care for Australians, particularly for residents in aged care facilities.


“As medication experts and the custodians of medicine safety, pharmacists must play an even greater role in the nation’s healthcare system by supporting aged care providers.


“PSA has been calling on the Government to provide funding for embedded pharmacists in residential aged care facilities for quite some time, to improve medication management, reduce medication-related harm, and to improve quality of life for their vulnerable residents.


“This will ensure that aged care facilities can consistently deliver a patient-centred, multidisciplinary service aimed at identifying, resolving and preventing medication-related problems such as polypharmacy and chemical restraint.


“It is crucial that service providers are allowed the flexibility to determine how they secure pharmacist services. Some facilities may choose to contract pharmacists through community pharmacies, some may choose to employ a pharmacist directly, or via a third party. It can’t be a one size fits all approach, as every facility is different.


“Every day that a pharmacist is not working alongside aged care staff in caring for older Australians, is a day residents are in danger from medication harm.


“Other recommendations include measures to address the unfair and inequitable pay disparity between pharmacists and other healthcare providers, and establishing a GP-Pharmacist Collaborative Prescribing Pilot in regional Australia to help address GP workforce shortages.


“Australian pharmacists have faced immense pressure over the past 24 months, and continue to be significantly underpaid for their services. Two key examples of this are case conferences – for which pharmacists are the only allied health provider that the government does not remunerate for their time and participation – and vaccinations administration (including COVID-19), where pharmacists are being remunerated at a much lower rate than other providers,” he said.


PSA thanks the Government for the opportunity to provide a submission for the 2022-23 Commonwealth Budget consultation process.


To view PSA’s 2022-23 Federal Budget Submission, please visit: https://www.psa.org.au/wp-content/uploads/2022/02/PSA-Federal-Budget-Submission-2022-2023.pdf


Media contact: PSA media 0424 777 463